Gustavo C. Román

Gustavo Román is a clinical neurologist practicing in Houston, Texas. During his academic career he has been interested in neuroepidemiology, tropical neurology, stroke, vascular, nutritional and infectious diseases of the nervous system. Most recently, he has studied autism and Alzheimer's disease. Since 2010, he works at the Neurological Institute of Houston Methodist Hospital where he is the Jack S. Blanton Presidential Distinguished Endowed Chair for the Study of Neurological Disease and...See more

Gustavo Román is a clinical neurologist practicing in Houston, Texas. During his academic career he has been interested in neuroepidemiology, tropical neurology, stroke, vascular, nutritional and infectious diseases of the nervous system. Most recently, he has studied autism and Alzheimer's disease. Since 2010, he works at the Neurological Institute of Houston Methodist Hospital where he is the Jack S. Blanton Presidential Distinguished Endowed Chair for the Study of Neurological Disease and Professor of Neurology at Weill Cornell Medical College, Cornell University, New York, N.Y. Born in Bogotá, Colombia, he received his medical degree from the National University of Colombia and began his specialization in neurology at the famous Hôpital de La Salpêtrière in Paris. He obtained the Diplôme d'Assistant Étranger (Neurologie et Neuropathologie) from the University of Paris, Faculty of Medicine Pitié-Salpêtrière, with a dissertation on lacunar strokes. He completed his neurology training at the University of Vermont and returned to Colombia where he served as neurology faculty in his Alma Mater. During this period he wrote two textbooks that had ample influence in Latin America: Practical Neurology (1982) and Tropical Neurology (1983)--the latter with Gabriel Toro and Lydia Navarro-Román, as coauthors. In collaboration with Dr. Bruce Schoenberg, then Director of Neuroepidemiology at the National Institutes of Health, NIH (Bethesda, Maryland) and Dr. Peter Spencer, neurotoxicologist at Albert Einstein College of Medicine (Bronx, New York), he conducted research on tropical spastic paraparesis (TSP) sponsored by the Colombian National Institute of Health. The Román husband-and-wife team described the natural history of a geographic cluster of TSP in Colombia and published comprehensive reviews on tropical myeloneuropathies. After receiving his board certification, Román joined the neurology faculty at Texas Tech University (Lubbock, Texas, USA) where he eventually became Professor and Interim Chair of the Department of Medical and Surgical Neurology. He resumed work with Schoenberg and Spencer on another outbreak of TSP, this time in the Seychelles Islands of the Indian Ocean. The retroviral origin of this new disease was eventually confirmed. Román edited the first book dedicated to the topic of HTLV-1 and the Nervous System (1989), with Jean-Claude Vernant (Martinique, France) and Mitsuhiro Osame (Kagoshima, Japan). In 1990, Román succeeded Dr. Schoenberg as Chief of Neuroepidemiology at the NIH and became one of the first Hispanics to reach the Branch Chief executive rank at this institution. He also served as Clinical Professor of Neurology at Georgetown University School of Medicine in Washington DC. At the NIH, Román continued research on HTLV-1-associated TSP in Japan, the Caribbean, South America, and the Seychelles; he organized a workshop that proposed the research criteria for vascular dementia (known as the Román criteria) used worldwide; he worked with the International League Against Epilepsy (ILAE) on Guidelines for Epidemiologic Studies on Epilepsy, particularly in tropical countries. With Oscar del Brutto (Ecuador) y Julio Sotelo (Mexico) wrote a book on neurocysticercosis and proposed measures for eradication of this infection, a leading cause of epilepsy in the tropics. He organized and conducted teaching courses on neuroepidemiology, a discipline that became a useful tool for Public Health research. His disciples and collaborators around the world formed a virtual neuroepidemiology network that continues to produce epidemiological data, particularly in the fields of dementia and Parkinson disease. One of his most challenging... See less